We are live on ! Find out more
GP

Geneva Partners Portfolio holdings

AUM $208M
1-Year Est. Return 72.91%
This Fund
S&P 500
This Quarter Est. Return
+13.22%
1 Year Est. Return
+72.91%
3 Year Est. Return
+251.81%
5 Year Est. Return
+429.32%
10 Year Est. Return
–
AUM
$106M
AUM Growth
+$18.4M
Cap. Flow
+$7.78M
Cap. Flow %
7.34%
Top 10 Hldgs %
47.47%
Holding
62
New
7
Increased
12
Reduced
31
Closed
8

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$4.93M
2
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$3.44M
3
AMGN icon
Amgen
AMGN
+$3.13M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$1.45M
5
LLY icon
Eli Lilly
LLY
+$1.45M

Top Sells

Rank Stock Value
1
BTT icon
BlackRock Municipal 2030 Target Term Trust
BTT
+$2.59M
2
AMT icon
American Tower
AMT
+$1.59M
3
UNH icon
UnitedHealth
UNH
+$937K
4
CVX icon
Chevron
CVX
+$636K
5
TMO icon
Thermo Fisher Scientific
TMO
+$595K

Sector Composition

Rank Sector Weight
1 Healthcare 26.81%
2 Energy 19.37%
3 Consumer Staples 14.5%
4 Industrials 11.54%
5 Technology 4.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PEP icon
1
PepsiCo
PEP
$198B
$6.6M 6.23%
36,529
+4,192
+13% +$748K
MRK icon
2
Merck
MRK
$325B
$5.92M 5.59%
53,360
+48,259
+946% +$4.93M
LMT icon
3
Lockheed Martin
LMT
$132B
$5.87M 5.54%
12,063
-152
-1% -$70.6K
IVV icon
4
iShares Core S&P 500 ETF
IVV
$863B
$5.69M 5.37%
14,811
+3,761
+34% +$1.45M
ELV icon
5
Elevance Health
ELV
$82.6B
$5.02M 4.74%
9,794
-360
-4% -$183K
CVX icon
6
Chevron
CVX
$383B
$4.93M 4.65%
27,448
-3,647
-12% -$636K
WMB icon
7
Williams Companies
WMB
$85.5B
$4.31M 4.07%
130,944
-3,970
-3% -$129K
LNG icon
8
Cheniere Energy
LNG
$54B
$4.19M 3.96%
27,930
+2,710
+11% +$453K
IJH icon
9
iShares Core S&P Mid-Cap ETF
IJH
$121B
$4.08M 3.85%
84,235
+71,190
+546% +$3.44M
HSY icon
10
Hershey
HSY
$37.6B
$3.66M 3.46%
15,798
+1,273
+9% +$293K
AMGN icon
11
Amgen
AMGN
$211B
$3.6M 3.4%
13,720
+11,675
+571% +$3.13M
MSFT icon
12
Microsoft
MSFT
$2.94T
$3.51M 3.31%
14,625
-2,119
-13% -$509K
FDRR icon
13
Fidelity Dividend ETF for Rising Rates
FDRR
$735M
$3.46M 3.27%
86,887
+2,813
+3% +$110K
NVO
14
Novo Nordisk
NVO
$226B
$2.82M 2.67%
41,702
+20,090
+93% +$1.18M
OKE icon
15
Oneok
OKE
$56.8B
$2.65M 2.5%
40,314
-208
-0.5% -$12.8K
GOOGL icon
16
Alphabet (Google) Class A
GOOGL
$4.11T
$2.64M 2.49%
29,915
-1,230
-4% -$117K
RSG icon
17
Republic Services
RSG
$68.1B
$2.57M 2.43%
19,962
-3,106
-13% -$414K
UNH icon
18
UnitedHealth
UNH
$387B
$2.47M 2.34%
4,664
-1,769
-27% -$937K
PM icon
19
Philip Morris
PM
$311B
$2.41M 2.28%
23,854
+45
+0.2% +$4.25K
MNST icon
20
Monster Beverage
MNST
$95.6B
$2.15M 2.03%
42,422
-2,400
-5% -$116K
MCK icon
21
McKesson
MCK
$106B
$2.07M 1.95%
5,508
-825
-13% -$308K
QUAL icon
22
iShares MSCI USA Quality Factor ETF
QUAL
$45.9B
$1.98M 1.87%
17,418
-1,792
-9% -$203K
CMI icon
23
Cummins
CMI
$83B
$1.65M 1.56%
6,796
-75
-1% -$17.8K
TMO icon
24
Thermo Fisher Scientific
TMO
$214B
$1.6M 1.51%
2,912
-1,123
-28% -$595K
ABT icon
25
Abbott
ABT
$191B
$1.55M 1.47%
14,131
-2,499
-15% -$259K
1
2 3

Similar funds

SPFA
Summit Place Financial Advisors Summit, New Jersey $208M AUM 29.36% 1-Year Est. Return
SWM
Steinberganna Wealth Management Huntington, New York $208M AUM
BWM
BlackDiamond Wealth Management New York $208M AUM 20.68% 1-Year Est. Return
EPG
Estate Planners Group Yardley, Pennsylvania $208M AUM
MCP
Miller Capital Partners Troy, Michigan $208M AUM
EM
ELCO Management New York $208M AUM 23.85% 1-Year Est. Return
MIM
Marshall Investment Management Littleton, Colorado $208M AUM 30.96% 1-Year Est. Return
MIP
Ma Investment Partnership Hillsborough, California $208M AUM

Geneva Partners's Q4 2022 Portfolio in Review

As of Q4 2022, Geneva Partners held 62 positions worth $106M, up 21% from $87.5M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Geneva Partners deployed $7.78M of net new capital in Q4 2022, opening 7 new positions and adding to 12 existing holdings. Its largest new stake was Eli Lilly: 4,090 shares worth $1.5M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 19% a quarter earlier, followed by Energy and Consumer Staples.

On the sell side, the largest reduction was UnitedHealth, an estimated $937K trimmed.

  • Geneva Partners's largest Q4 2022 buy was Eli Lilly: 4,090 shares worth $1.5M.
  • Geneva Partners added most to Merck in Q4 2022, an estimated $4.93M increase.
  • Geneva Partners's biggest Q4 2022 reduction was UnitedHealth, cutting an estimated $937K.
  • Geneva Partners fully exited BlackRock Municipal 2030 Target Term Trust in Q4 2022, selling an estimated $2.59M.
  • Geneva Partners's ten largest holdings make up 47% of its $106M portfolio in Q4 2022.
  • Geneva Partners opened 7 new positions and closed 8 in Q4 2022.
  • Geneva Partners's portfolio value rose 21% quarter-over-quarter to $106M.

Based on Geneva Partners's 13F filing for Q4 2022, filed 23 Jan 2023.